Combinations of a glutamine antagonist and α-ketoglutarate or a cell-permeable derivative thereof, and their use in the treatment of neoplastic disease.
AU2026906042P0Pending Publication Date: 2026-07-16MASON PAUL
0 Cites 0 Cited by
Patent Information
- Application Number
- AU2026906042
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-07-04
- Publication Date
- 2026-07-16
Need to check novelty before this filing date? Find Prior Art
No text content released.